|Application:||Gene expression microarray analysis|
|Number of samples:||37|
|Release date:||Dec 15 2006|
|Last update date:||Oct 29 2018|
|Dataset link||MCF7 inhibitor|
MCF-7 human breast cancer cells were incubated from 5min to 90min after administration of the growth hormone (heregulin (HRG)), the kinase inhibitor (U0126 (a MEK inhibitor), AG1478 (an EGFR kinase inhibitor) or both growth hormone and one of kinase inhibitor. Control was set as growth hormone/inhibitor non-treated cells. For each inhibitor, one control was used.